wr 1065 has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Josef, E; Biggar, S; Bonner, HS; Han, S; Kaplan, I; Kelly, L; Prokop, S; Shaw, LM; Stamos, B; Tobi, M; Vargas, BJ | 1 |
| Gall, HE; Korst, AE; van der Vijgh, WJ; Vermorken, JB | 1 |
2 other study(ies) available for wr 1065 and Adenocarcinoma
| Article | Year |
|---|---|
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury.
Topics: Adenocarcinoma; Administration, Topical; Amifostine; Analysis of Variance; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Intestinal Mucosa; Male; Mercaptoethylamines; Multivariate Analysis; Prostatic Neoplasms; Radiation-Protective Agents; Rectum; Telangiectasis; Time Factors | 2002 |
Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.
Topics: Adenocarcinoma; Amifostine; Ascites; Chromatography, High Pressure Liquid; Disulfides; Half-Life; Humans; Infusions, Intravenous; Male; Mercaptoethylamines; Middle Aged; Radiation-Protective Agents; Stomach Neoplasms | 1996 |